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Abstract 
Introduction 
Open right-sided transthoracic esophagectomy with one-lung ventilation (OLV) triggers 
a massive inflammatory reaction. The influence of the OLV on the inflammatory 
cascade is unclear. Data on the inflammatory response in the ventilated left and 
collapsed right lung, respectively, is scarce. The aim of this study was to analyze this 
reaction in bronchoalveolar lavage (BAL) fluid from both lungs, the right pleural space 
and the peripheral blood. 
Methods 
Concentrations of interleukin (IL)-6, IL-8, IL-10 and IL-1RA in the BAL fluids from the 
right and left lungs, respectively, in the peripheral blood and in the right pleural space 
in patients undergoing transthoracic esophagectomy for cancer was determined with 
enzyme-linked immune-sorbent assays in 29 patients. 
Results 
The assay of the pro-inflammatory cytokines of the bilateral BAL fluids showed 
significant higher concentrations on the ventilated left lung at the time of extubation. 
The anti-inflammatory response was only seen in IL-1RA, but not in IL-10, and mostly 
restricted to the ventilated left lung. In the blood, only IL-6, IL-10 and IL-1RA increased 
whereas IL-8 showed little reaction. The response was observed already at the end of 
surgery, indicating a fast reaction to the surgical and anesthetic trauma. In the pleural 
fluid, all cytokine concentrations increased, and the highest values were detected on 
day one post surgery, and decreased thereafter. Pulmonary complications or 
anastomotic leakage did not affect the cytokine concentrations.  
Conclusion 
Both the ventilated left and the collapsed right lung showed an inflammatory response. 
The response was more pronounced on the ventilated left side and the time courses 
were significantly different. In the blood, the pro-inflammatory IL-6 and both anti-
inflammatory cytokines increased and the response occurred fast. All cytokines 
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increased in the pleural cavity. The findings underline the complexity of the 
inflammatory reaction associated with OLV in transthoracic esophagectomy. 
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Introduction 
Open right-sided transthoracic esophagectomy with one-lung ventilation (OLV) is one 
of the standard surgical approaches for curative treatment of esophageal cancer 
(abdomino-thoracic or thoraco-abdomino-cervical esophagectomy). The OLV leads to 
a complete collapse of the right lung with subsequent shunting of blood and the risk of 
hypoxemia. 
 
The procedure triggers a massive inflammatory reaction with production of various 
cytokines such as the pro-inflammatory interleukin-6 (IL-6) and IL-8 and the anti-
inflammatory cytokines IL-10 and IL-1 receptor antagonist (IL-1RA) [1,2]. Elevated 
concentrations of these interleukins have been measured in bronchoalveolar lavage 
(BAL) fluid, peripheral blood, and in the pleural space [3,4]. Elevated levels of anti-
inflammatory cytokines in bronchoalveolar fluid have been reported to correlate with 
the development of the acute respiratory distress syndrome (ARDS) and low 
concentrations of anti-inflammatory cytokines were associated with poor prognosis in 
patients with ARDS [5,6].  
 
In esophagectomy, pulmonary complications are frequent with rates of up to 40% [7]. 
Impaired respiratory mechanics due to thoracotomy and laparotomy, pre-existing 
pulmonary co-morbidity, and the inflammatory reaction with release of oxygen radicals 
and resultant lung injury are possible explanations for these complications. 
 
 Although a few studies have addressed the production of cytokines and the 
inflammatory reaction in esophagectomy, the mechanisms are still not well defined. 
The influence of the OLV on the inflammatory cascade is unclear and the data on the 
inflammatory reaction in the ventilated left and collapsed right lung, respectively, is 
scarce. Different mechanisms may induce lung injury after OLV, such as 
ischemia/reperfusion injury in the collapsed lung, ventilator-induced injury, hyperoxia, 
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volume overload and increased capillary stress in the ventilated lung [8,9,10]. Cree et 
al. demonstrated significant higher IL-8 levels in the BAL fluid after surgery compared 
to the peripheral blood but did not show a difference between the collapsed and 
ventilated lung groups [4]. However, the BAL fluid samples were taken from different 
patients. As cytokine production varies substantially between patients, this might have 
introduced a selection bias.  
The aim of this study was to analyze the inflammatory reaction, represented by the 
concentrations of IL-6, IL-8, IL-10 and IL-1RA in BAL fluid of the ventilated left and 
collapsed right lungs, in the peripheral blood and in the right pleural space in patients 
undergoing transthoracic esophagectomy for cancer. 
 
Patients and methods 
From the 1st January 2006 all patients undergoing transthoracic esophagectomy for 
cancer at the Triemli Hospital Zurich and the University Hospital Basel were assessed 
for eligibility to be included in a prospective, randomized, double-blinded trial to 
analyze the influence of n-acetylcysteine (NAC) on pulmonary morbidity (trial ongoing). 
The trial is registered by the National Library of Medicine at www.clinicaltrials.gov 
under the number NCT00512265. The study was approved by the Ethics committees 
of the two participating hospitals. Informed consent was obtained from all patients. In 
the first 30 patients included in the NAC trial, cytokine analysis was performed for this 
study. One patient was excluded as an intra-operative decision was made to perform a 
transhiatal esophagectomy, resulting in data from of 29 patients being available for 
analysis.  
 
Neoadjuvant treatment, surgery and anesthetic procedure 
All patients with advanced tumors (T3 and / or N+) received neoadjuvant treatment. 
This usually entailed chemotherapy with 5-fluorouracil and cisplatin, and an irradiation 
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dose of 45-50 Gray. Surgery was performed 6-8 weeks after completion of the 
combined pre-treatment. 
Esophagectomies were done using the abdomino-thoracic (Ivor-Lewis resection) and 
the thoraco-abdomino-cervical (3-stage) approach in 23 and 6 patients, respectively. In 
the latter group, the cervical phase was performed simultaneously to the abdominal 
phase, thus not prolonging the procedure. In all patients the stomach was used as 
conduit for reconstruction. The anastomosis was either stapled or hand-sewn, 
according to the surgeon’s preference. Two thoracic drains (28 French anterior and 32 
French posterior) were inserted into the thoracic cavity before closure of the 
thoracotomy. The posterior drain was left in place for a minimum of 5 days. A contrast 
swallow was performed on postoperative day five. 
Anesthetic procedures were standardized for all patients including the use of double-
lumen endobronchial tubes under fiber-optic control to allow single lung ventilation and 
use of thoracic epidural catheters with continuous infusion of local anesthetics both 
intraoperatively (ropivacaine 0.3%) and up to five days postoperatively (bupivacaine 
0.125%). Total intravenous anesthesia was applied using bolus doses of fentanyl and 
continuous infusions of propofol and remifentanil intraoperatively and tempered until 
endotracheal extubation. Muscle relaxation (intraoperatively only) was achieved using 
bolus doses of rocuronium. One-lung ventilation during thoracotomy followed the 
principles of a lung protective strategy, using pressure-limited or pressure-controlled 
ventilation modes with tidal volumes of <7 ml/kg body weight, positive end-expiratory 
pressure of 3-5 cm H2O and limiting peak inspiratory pressures to <30 cm H2O . 
Inspired oxygen concentration on the ventilated lung was set to 100% at the beginning 
and gradually reduced thereafter based on the arterial oxygen tension measured by 
repeated blood gas analyses [11,12,13]. Extubation was performed on the morning of 
the first postoperative day with the exception of six patients who were extubated within 
four hours of the completion of the surgery.  
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Continuous monitoring included ECG analysis, measurement of arterial oxygen 
saturation with pulse oxymetry and invasive arterial as well as central venous pressure 
monitoring. Blood samples were drawn intermittently at predefined time points for 
blood gas and further laboratory parameter analysis. 
 
BAL, pleural lavage and peripheral blood samples 
Bilateral BAL was performed after intubation, at the completion of surgery and prior to 
extubation. In the six patients that were extubated within 4 hours postoperatively only 
the first two bilateral BAL’s were performed (at intubation and end of surgery). The 
bronchoscope was wedged in the lower bronchus of both lungs and a lavage with 50ml 
of sterile saline was performed. The BAL fluid was immediately centrifuged at 2000rpm 
for 15 minutes and the supernatant stored at -20°C. 
Pleural samples were obtained after amending the initial protocol following the first 12 
patients. To analyze the pleural inflammatory reaction, lavage of the pleural space 
after thoracotomy and before closure of the thoracotomy with 100ml of sterile saline 
was performed. On day 1-3, pleural fluid samples were taken in a standardized way 
directly from the pleural tubes. The fluid was processed as described above for the 
BAL samples. 
Peripheral venous blood samples were obtained at the same time as the BAL and 
pleural fluid samples on the day of surgery and on day 1-3. Again, the samples were 
processed as described. 
 
Cytokine assays 
The concentrations of IL-6, IL-8, IL-10 and IL-1RA in the BAL, pleural space and blood 
samples were determined with enzyme-linked immune-sorbent assays (ELISA, R & D 
Systems, Minneapolis, MN, USA). To standardize the BAL fluid samples for optimal 
comparison, we extrapolated the results retrieved in the ELISA to a sample volume of 
10ml. 
 8 
 
Statistical analysis 
Comparison of data between the groups was undertaken using Chi-square tests for 
categorical data, and Wilcoxon signed rank tests for continuous data. To analyze the 
influence of time on the cytokine response, a regression model using an interaction 
term for group and time was developed. Postoperative morbidity was classified as 
surgical, pulmonary or medical. Surgical morbidity included anastomotic leak, thoracic 
empyema, chyle leak and rethoracotomy or relaparotomy. An anastomotic leak was 
defined as contrast extravasation during a contrast swallow study. Pulmonary 
morbidity included postoperative pneumonia, pleural effusion requiring intervention 
and ARDS. Medical morbidity included cardiac complications such as arrhythmias 
needing intervention or renal failure.  
An analysis to assess whether the concentrations of cytokines in the different 
compartments were different in patients with and without complications was 
performed. This analysis was stratified according type of complication: complications 
that were results of the change of the immune system such as pulmonary and medical 
complications, pulmonary complications alone and the major surgical complication, 
anastomotic leakage. Atrial fibrillation was included in the complications that were 
results of the change of the immune system [14]. 
Data is presented in mean with standard deviation (SD) or median with inter-quartile 
range (IQR) as appropriate. Statistical significance for each model was set at p<0.05. 
Statistical analyses were performed with SPSS®, Version 16 for Windows and 
GraphPad InStat Version 3.1a for Macintosh, GraphPad Software, San Diego 
California USA. 
 
Results 
Patients, pathology and morbidity 
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There were 26 men and 3 women in the study group. The mean age was 63.1 years 
(SD 9.6 years) and mean body mass index was 25.8 kg/m2 (SD 4.0 kg/m2). 
Preoperative spirometry showed a mean forced expiratory volume (FEV1) of 2.8 liters 
(SD 0.8 liters) and a mean vital capacity (VC) of 4.1 liters (SD 0.8 liters). The mean 
percentage FEV1/VC was 69.7% (SD 11.7%). Mean cardiac ejection fraction was 
58.6% (SD 8.3%). Six patients (20.7%) had pulmonary comorbidities, five patients 
(17.2%) cardiac comorbidities, six patients (20.7%) presented with non-insulin 
dependent diabetes and one patient (3.5%) with pre-existing renal impairment. 
 
There were 19 patients with adenocarcinoma and 10 with squamous cell carcinoma. 
17 patients received neoadjuvant radio-chemotherapy and 12 patients proceeded 
directly to surgery. In 23 patients, an abdomino-thoracic technique and in six patients a 
thoraco-abdomino-cervical technique was used. No difference in duration of surgery or 
blood loss occurred between these different techniques (median 270 minutes in both 
techniques, p=0.333; 500 mls versus 400 mls, p=0.609). International Union against 
cancer (UICC) stages were as follows: four patients (14%) with stage 0, seven patients 
(24%) with stage I, nine patients (31%) with stage IIA, six patients (21%) with stage IIB 
and three patients (10%) with stage III. 
There was one in-hospital death on postoperative day 30 in a patient with an 
anastomotic leak and mediastinitis. Morbidity is shown in table 1. The six anastomotic 
leaks included two cervical and four intra-thoracic. Both cervical leaks were treated 
conservatively; three patients with intra-thoracic leaks underwent re-thoracotomy and 
suture repair. 
15 patients received NAC and 14 received the placebo (glucose 5%). No significant 
differences in cytokine concentration in BAL fluid, peripheral blood and pleural fluid 
between patients with and patients without NAC were detected.  
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BAL fluid cytokine assay 
Both lungs were affected by the surgical procedure. The cytokine response showed 
substantial variability for the individual patients (Figures 1a-f).The assay of the pro-
inflammatory cytokines of the bilateral BAL fluids showed significant higher 
concentrations on the ventilated left side at the time of extubation (table 2).  
The anti-inflammatory response was only seen in IL-1RA, but not in IL-10, and mostly 
restricted to the left lung. Again, the response was most marked at time of extubation. 
The regression model using an interaction term for group and time showed that there 
was a significant effect in the time progression in IL-6 (p=0.003), IL-8 (p=0.002) and IL-
1RA (p=0.001), respectively, but not in IL-10 (p=0.572).  
The calculation of the ratios of cytokine increase, taking the cytokine concentration at 
the intubation as a baseline, showed that the pro-inflammatory cytokines increased 
substantially, especially IL-6, whereas the anti-inflammatory cytokines reacted less 
pronounced (Table 2).  
 
Blood cytokine assay 
Of the pro-inflammatory cytokines, only IL-6 increased in the blood whereas IL-8 
showed little reaction (table 2). Of the anti-inflammatory cytokines, both IL-10 and IL-
1RA increased in the blood. The increase was already observed at the end of surgery, 
thus only a few hours after the surgical trauma occurred. The ratio calculation showed 
that IL-6 and IL-1RA increased most pronounced (table 3).  
 
Pleural fluid cytokine assay 
All cytokines increased substantially after surgery. The highest concentration was 
measured in all cytokines on day one post surgery, and decreased thereafter. The 
ratio calculation showed that all cytokines increased substantially, more than in the 
BAL fluid or in the blood. IL-6 and IL-1RA reacted the most with day one ratios of 103 
and 25, respectively. Comparison of cytokine concentrations in the pleural fluid and the 
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peripheral blood revealed higher levels in the pleural fluid for all cytokines throughout 
the measurement period with exception of IL-10 (table 3). 
 
Patients with versus patients without complications 
At no time was any significant difference in interleukin levels of any compartment 
observed in patients with and without complications that are results of changes in the 
immune system. Also, no difference between patients with pulmonary complications or 
anastomotic leak in any of the compartments was detected. 
 
Patients with versus patients without neoadjuvant radiochemotherapy 
A comparison of the initial inflammatory status of the 17 patients who received 
neoadjuvant radio-chemotherapy compared with the 12 patients that proceeded 
directly to surgery is shown in Table 4. 
 
Discussion 
In all patients, both lungs were affected. There was a difference between pro-
inflammatory cytokine concentrations in BAL fluid of the ventilated left and the 
collapsed right lung. The concentrations of the pro-inflammatory cytokines IL-6 and IL-
8 were significantly higher in the ventilated left lung before the delayed extubation. The 
ratio analysis showed that IL-6 had the most pronounced increase. The anti-
inflammatory response was represented by IL-1RA, whereas no notable increase in IL-
10 occurred. There was also a significant influence of time in the concentrations of IL-
6, IL-8 and IL-1RA, indicating that not only extend of the inflammatory response is 
different in the two lungs, but also the timing. To our knowledge, no other study has 
analyzed cytokine levels and time course during OLV in both lungs in the same 
patient. Cree at al. examined ventilated left and collapsed right lungs of two different 
groups of patients and found no significant difference in cytokine concentration [4]. 
However, as these and other authors state, cytokine concentrations vary considerably 
Gelöscht: B
Gelöscht:  by the OLV 
and the surgical procedure
 12 
between patients, thus inflicting a bias [4,5]. Our data support this statement. The 
different time course of cytokine concentrations may furthermore represent the 
different mechanisms that trigger the inflammatory reaction. The increase in 
concentration of the pro-inflammatory cytokines IL-6 and IL-8 is longer and more 
pronounced in the ventilated left lung compared to the collapsed right lung. A similar 
finding was described in two groups of patients with a low and high ratio of OLV to total 
ventilation time (<35% and >35%), respectively [15]. These authors showed non-
significant higher BAL fluid IL-6 concentrations in the group with low OLV to total 
ventilation time ratio. In contrast to our results, these authors did not show any 
difference in IL-8 concentrations.  
 
A number of factors may be responsible for the development and severity of 
inflammatory reactions during OLV. The ischemia/reperfusion in the collapsed lung 
triggers an inflammatory response that may lead to lung injury [9]. In the ventilated 
lung during OLV, high oxygen concentrations are necessary to maintain adequate 
oxygenation, producing reactive oxygen species and subsequently triggering an 
inflammatory reaction [8,16]. Additionally, mechanical ventilation can cause 
mechanical stress on alveolar walls known as barotrauma or volutrauma, initiating a 
cytokine response [17,18,19]. Our findings indicate that the inflammatory reaction on 
the ventilated left lung is prolonged compared to the collapsed right lung. 
The findings underline the importance of improving the mechanical ventilation in OLV 
to attenuate the inflammatory reaction and to protect the left lung. Although the 
principles of a lung protective ventilation strategy were followed in this study (lower 
tidal volumes, positive end-expiratory pressure and limited peak airway pressures), the 
inflammatory response to mechanical ventilation appears to be substantial. A number 
of studies have analyzed the influence of protective ventilation strategies on the 
cytokine reaction, with inconsistent results [18,20,21,22]. Promising results were 
obtained in a study comparing two-lung high-frequency jet ventilation with standard 
 13 
OLV in patients undergoing transthoracic esophagectomy [23]. The two-lung jet 
ventilated patients showed a lower PCO2 with adequate oxygenation. However, no 
measurements to analyze the inflammatory reactions were performed.  
 
In the blood, the pro-inflammatory reaction was mainly represented by the increase of 
IL-6, but not IL-8, which was detectable only locally in the BAL fluid and the pleural 
fluid. Both anti-inflammatory cytokines increased in the blood, with IL-1RA being more 
pronounced. Interestingly, the systemic reaction occurred already at the end of surgery 
and was therefore very fast since it was observed a few hours after the surgical and 
anesthetic trauma. Transthoracic esophagectomies have been shown to trigger higher 
interleukin concentrations in the peripheral blood compared to 
pancreaticoduodenectomies or transhiatal esophagectomies [24,25]. The intrathoracic 
phase of the operation seems to be responsible for the more severe inflammatory 
response. In addition, the systemic response may be attenuated by the suppression of 
circulating white blood cells such as monocytes or T-helper lymphocytes [26]. Whether 
the production of IL-10 is less attenuated in the peripheral blood, leading to the higher 
concentrations compared to the BAL fluid, is unclear. Van Sandick et al. showed a 
depression of IL-10 production in vitro in patients undergoing esophagectomy [26].  
 
The inflammatory response in the compartment where the surgery is performed, i.e. 
the right sided thoracic cavity, has not been studied previously in detail. Two studies 
analyzed the concentrations of the pro-inflammatory cytokines IL-6 and IL-8 in pleural 
drainage fluid and peripheral blood and found significantly higher levels in the pleural 
samples [3, 27]. Our results are consistent with these reports. To our knowledge, no 
study analyzed the course of anti-inflammatory cytokines in the pleural space. Both IL-
10 and IL-1RA concentrations were markedly higher in the pleural fluid compared to 
the peripheral blood. The concentrations of the anti-inflammatory cytokines increase 
until day one after surgery, followed by a subsequent slow decrease. On day three the 
Gelöscht: already 
 14 
concentrations were still clearly higher than at the beginning of the surgery. This may 
be influenced by the thoracic drains, which stayed in place for a minimum of five days. 
 
The analysis of the patients with complications versus patients without complications 
did not reveal any differences at any time point or in any cytokine type. We were not 
able to reproduce the findings of Szczesny et al, who demonstrated IL-6 and IL-1 in 
pleural fluid to be a marker for postoperative complications in a small cohort of 27 
patients undergoing lobectomy or pneumonectomy [28]. The groups in their study 
showed significant differences in age (patients with complications were older), and 
length of surgery (longer in patients with complications). Although the authors argue 
that these factors are non-immunological, we believe that they still might have had an 
influence as immune response might be less pronounced in older patients and longer 
operation times might have had an influence on time course and dimension of immune 
response. 
Pulmonary complications per se did not result in an altered inflammatory response. A 
subclinical anastomotic leak may also increase the pleural inflammatory response. 
However, the comparison between the patients who were diagnosed with an 
anastomotic leak and those without, respectively, did not reveal any differences in 
cytokine concentrations. As the groups were small, no definite conclusion can be 
drawn. The clinical relevance of the inflammatory responses in the different 
compartments is unclear and has yet to be analyzed in further studies. 
 
The patients of this study were also enrolled in a prospective randomized trial 
analyzing the effect of NAC on pulmonary morbidity. Fifteen patients received NAC 
and 14 not. This might have influenced the inflammatory response and needs to be 
acknowledged as a limitation. However, there is no data on the effect of NAC in 
esophagectomy. We compared the patients with and without NAC and found no 
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differences in cytokine response in any compartment. Thus we believe that NAC has 
not biased the results. 
 
A number of patients underwent neoadjuvant radio-chemotherapy. The interval 
between pretreatment and surgery was 6-8 weeks. We performed a sub-analysis 
comparing the initial blood cytokine levels in patients with and without neoadjuvant 
treatment. The results showed no statistical difference in the cytokines except for IL-6, 
which is most likely caused by a type 1 error. Literature on the perioperative 
inflammatory response after neoadjuvant treatment is scarce. Endo et al. assessed 
cytokine production in patients with small lung cell cancer who underwent preoperative 
chemotherapy with cisplatin and docetaxel and found an increased cytokine production 
during the perioperative period [29]. As the numbers in our study are small, careful 
interpretation of these results is necessary and further studies are necessary to 
analyze the impact of neoadjuvant treatment on the perioperative cytokine response. 
 
Conclusion 
The findings of this study underline the complexity of the inflammatory reaction 
associated with transthoracic esophagectomy. The response of pro- and anti-
inflammatory cytokines arises in both the ventilated left and the collapsed right lungs. 
The response is more pronounced on the ventilated left side and the time courses are 
significantly different. In the blood, the pro-inflammatory IL-6 and both anti-
inflammatory cytokines increased. The response occurred early after the surgical and 
anesthetic trauma. All cytokines increased in the pleural cavity.  
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Table 1 
Morbidity shown as medical, surgical and pulmonary morbidity.  
Surgical morbidity total 
 No 
 Yes 
 
21 
8 
Leak 
 No 
 Yes 
 
23 
6 
Rethoracotomy  
 No 
 Yes 
 
25 
4 
Relaparotomy 
 No 
 Yes 
 
27 
2 
Pulmonary morbidity total 
 No 
 Yes 
 
12 
17 
Effusion 
 No 
 Yes 
 
22 
7 
Pneumonia 
 No 
 Yes 
 
16 
13 
ARDS 
 No 
 Yes 
 
28 
1 
Medical morbidity total 
 No 
 Yes 
 
22 
7 
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Table 2 
Comparison of the cytokine levels in the BAL fluid of the right and left lung and the levels in the peripheral blood. 
 
 
 
 
BAL COLLAPSED 
RIGHT LUNG 
RATIO OF 
CYTOKINE 
RESPONSE 
COLLAPSED RIGHT 
LUNG* 
BAL VENTILATED 
LEFT LUNG 
RATIO OF CYTOKINE 
RESPONSE 
VENTILATED LEFT 
LUNG* 
P VALUE# 
BAL RIGHT LUNG 
COMPARED TO 
BAL LEFT LUNG 
IL-6 (PG/ML), MEDIAN (IQR) 
 AT INTUBATION 
 END OF SURGERY 
 BEFORE EXTUBATION 
 
 
54 (17-113) 
959 (135-2297) 
428 (174-1217) 
 
 
12.1 
6.4 
 
48 (29-114) 
669 (328-1391) 
1045 (137-5829) 
 
 
9.4 
12.8 
 
0.598 
0.258 
0.044 
IL-8 (PG/ML), MEDIAN (IQR) 
 AT INTUBATION  
 END OF SURGERY  
 BEFORE EXTUBATION  
 
 
2015 (498-3681) 
4933 (1738-21384) 
11515 (4397-18807) 
 
 
3.9 
4.1 
 
2077 (1152-4398) 
5472 (1540-11437) 
23097 (7696-62921) 
 
 
2.3 
6.6 
 
0.745 
0.150 
0.038 
IL-10 (PG/ML), MEDIAN (IQR) 
 AT INTUBATION  
 END OF SURGERY  
 BEFORE EXTUBATION  
 
 
0 (0-7) 
35 (0-79) 
0 (0-9) 
 
 
2.5 
0 
 
0 (0-8) 
15 (0-33) 
3 (0-25) 
 
 
2.1 
1.3 
 
0.715 
0.063 
0.117 
IL-1RA (PG/ML), MEDIAN (IQR) 
 AT INTUBATION  
 END OF SURGERY  
 BEFORE EXTUBATION  
 
 
5838 (2035-12379) 
11390 (5659-40199) 
10245 (6689-18663) 
 
 
2.4 
2.6 
 
6519 (2600-12402) 
8775 (3029-23165) 
33780 (9041-109282) 
 
 
1.1 
3.2 
 
0.745 
0.089 
0.092 
*Concentration at intubation as base line for calculation of ratio 
# Wilcoxon paired samples test 
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Table 3 
Comparison of the cytokine levels in the pleura fluid with the levels in the peripheral blood. The pleural samples were taken immediately after the 
thoracotomy and before closure of the thoracotomy. On day 1-3 the pleural and peripheral blood samples were taken at the same time. 
 
 
 
 
PLEURAL FLUID RATIO OF CYTOKINE 
RESPONSE PLEURAL 
FLUID* 
PERIPHERAL 
BLOOD 
RATIO OF CYTOKINE 
RESPONSE 
PERIPHERAL 
BLOOD* 
P VALUE# 
PLEURAL FLUID 
VERSUS BLOOD 
IL-6 (PG/ML), MEDIAN (IQR) 
 AT THORACOTOMY/INTUBATION 
 END OF SURGERY  
 DAY 1  
 DAY 2  
 DAY 3  
 
 
399 (0-702) 
1799 (659-3046) 
52124 (27311-68355) 
26755 (16796-41109) 
10583 (7047-28171) 
 
 
2.5 
103.3 
39.1 
19.5 
 
0 (0-12) 
134 (76-208) 
146 (98-224) 
86 (56-145) 
51 (24-98) 
 
 
11.1 
11.9 
4.9 
4.2 
 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
 
IL-8 (PG/ML), MEDIAN (IQR) 
 AT THORACOTOMY/INTUBATION  
 END OF SURGERY  
 DAY 1  
 DAY 2 
 DAY 3 
 
 
28 (0-216) 
222 (31-319) 
705 (296-1232) 
589 (230-1289) 
417 (201-951) 
 
 
1.1 
6.6 
5.3 
2.9 
 
0 (0-22) 
10 (0-48) 
0 (0-45) 
0 (0-28) 
0 (0-38) 
 
 
1.1 
1.4 
1.3 
1.2 
 
0.040 
<0.001 
<0.001 
<0.001 
<0.001 
IL-10 (PG/ML), MEDIAN (IQR) 
 AT THORACOTOMY/INTUBATION 
 END OF SURGERY 
 DAY 1 
 DAY 2 
 DAY 3 
 
 
0 (0-25) 
10 (0-44) 
317 (237-392) 
234 (152-285) 
155 (106-217) 
 
 
0.8 
11.9 
9.4 
7.3 
 
15 (0-258) 
75 (38-276) 
62 (12-323) 
46 (6-281) 
57 (6-317) 
 
 
1.2 
1.3 
1.4 
1.4 
 
0.022 
<0.001 
0.051 
0.098 
0.855 
IL-1RA (PG/ML), MEDIAN (IQR) 
 AT THORACOTOMY/INTUBATION 
 END OF SURGERY 
 DAY 1 
 DAY 2  
 DAY 3 
 
 
62 (0-803) 
1137 (319-1837) 
7152 (3834) 
5314 (11758) 
3807 (3457-8991) 
 
 
3.0 
24.9 
5.9 
4.3 
 
63 (0-780) 
5053 (1048-11533) 
961 (357-1502) 
436 (171-1297) 
397 (145-2085) 
 
 
9.8 
1.6 
1.1 
1.7 
 
0.380 
<0.001 
<0.001 
<0.001 
<0.001 
 
*Concentration at intubation as base line for calculation of ratio 
# Wilcoxon paired samples test 
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Table 4 
Comparison of basic serum cytokine levels of patients who underwent neoadjuvant 
radio-chemotherapy and patients who proceeded directly to surgery. 
 NEOADJUVANT 
TREATMENT 
N=17 
NO NEOADJUVANT 
TREATMENT 
N=12 
P VALUE# 
IL-6 (PG/ML), MEDIAN (IQR) 3 (0-18) 0 (0-0) 0.040 
IL-8 (PG/ML), MEDIAN (IQR) 0 (0-50) 0 (0-0) 0.088 
IL-10 (PG/ML), MEDIAN (IQR) 50 (0-694) 12 (0-32) 0.262 
IL-1RA (PG/ML), MEDIAN (IQR) 139 (0-1586) 43 (0-263) 0.510 
#Mann-Whitney-U test 
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Figure 1a 
Course of the IL-6 concentrations on the right side in the 29 individual patients at 
intubation, at the end of surgery and before extubation. 
 
Figure 1b 
Course of the IL-6 concentrations on the left side in the 29 individual patients at 
intubation, at the end of surgery and before extubation. 
 
Figure 1c 
Course of the IL-8 concentrations on the right side in the 29 individual patients at 
intubation, at the end of surgery and before extubation.  
 
Figure 1d 
Course of the IL-8 concentrations on the left side in the 29 individual patients at 
intubation, at the end of surgery and before extubation.  
 
Figure 1e 
Course of the IL-1RA concentrations on the right side in the 29 individual patients at 
intubation, at the end of surgery and before extubation.  
 
Figure 1f 
Course of the IL-1RA concentrations on the left side in the 29 individual patients at 
intubation, at the end of surgery and before extubation.  
 
